School of Pharmacy and Biomedical Sciences
Maudland Building, MB136
+44 (0) 1772 89 6488
Subject Areas: Pharmacy and Pharmacology
Dr Andrew Lunn is a Lecturer in Pharmaceutics in the School of Pharmacy and Biomedical Sciences. He completed his MPharm degree at Liverpool John Moores' School of Pharmacy in 2012 and his pre-registration training at Imperial College Hospital. Whilst continuing to practice, he then went on to complete an MSc and PhD in Chemistry at Warwick University. His PhD focussed on the synthesis and biological interactions of glycopolymer nanoparticles, and their use in the targeted delivery of antibiotics.
Dr Andrew Lunn is a Lecturer in Pharmaceutics in the School of Pharmacy and Biomedical Sciences, with experience in both hospital and community pharmacy, and an interest in the use of natural and synthetic polymers for drug delivery.
He graduated from the Liverpool John Moores School of Pharmacy in 2012 with an MPharm degree, and then completed his pre-registration year at Imperial College Hospital including various clinical and non-clinical rotations.
His PhD focussed on the synthesis of investigative glycopolymer nanoparticles via RAFT emulsion polymerisation, and more scalable equivalents using variations upon traditional emulsion polymerisation. The systems produced were used to probe the biological interactions of glycopolymers with lectins and applied to deliver antibiotics in a targeted responsive manner to mycobacteria infected macrophages.
His current research focus is on the scalable synthesis of targeted drug delivery agents using biopolymer carbohydrates, particularly for use as inhaled therapies in lung cancer. He is dedicated to investigating systems that can be easily be translated from the lab bench to the patient bedside, to make a real clinical impact.
Andrew is a GPhC registered pharmacist and a member of the Royal Pharmaceutical Society and the UK and Ireland controlled release society. He is also an associate member of the Royal Society of Chemistry. He works to deliver truly integrated pharmacy teaching with expertise in chemistry, pharmaceutics and practice.
Development of novel therapeutics using biopolymer carbohydrates
Targeted, responsive chemotherapy delivery lung cancer using biopolymer carbohydrates